133 related articles for article (PubMed ID: 38884342)
1. Co-exposure to gamma-hydroxybutyrate is associated with attenuated neuropsychiatric and stimulant effects of metamfetamine.
Greene SL; Syrjanen R; Hodgson SE; Abouchedid R; Schumann J
Clin Toxicol (Phila); 2024 May; 62(5):303-313. PubMed ID: 38884342
[TBL] [Abstract][Full Text] [Related]
2. Characteristics of analytically confirmed gamma-hydroxybutyrate (GHB) positive patients in the emergency department: presentation, poly-drug use, disposition and impact on intensive care resource utilisation.
Stockham P; Partridge E; Alfred S; Boyle L; Camilleri A; Green H; Haustead D; Humphries M; Kostakis C; Mallon J
Clin Toxicol (Phila); 2023 Apr; 61(4):241-247. PubMed ID: 37129222
[TBL] [Abstract][Full Text] [Related]
3. Analytically confirmed illicit and novel psychoactive drug use in Western Australian emergency departments: initial results from the Emerging Drugs Network of Australia (EDNA).
Weber C; Smith JL; Soderstrom J; Burrows S; McCutcheon D; Oosthuizen F; Fatovich DM;
Clin Toxicol (Phila); 2023 Jul; 61(7):500-508. PubMed ID: 37449677
[TBL] [Abstract][Full Text] [Related]
4. Presentations to an urban emergency department in Switzerland due to acute γ-hydroxybutyrate toxicity.
Liakoni E; Walther F; Nickel CH; Liechti ME
Scand J Trauma Resusc Emerg Med; 2016 Aug; 24(1):107. PubMed ID: 27581664
[TBL] [Abstract][Full Text] [Related]
5. Characteristics and time course of benzodiazepine-type new psychoactive substance detections in Australia: results from the Emerging Drugs Network of Australia - Victoria project 2020-2022.
Syrjanen R; Greene SL; Weber C; Smith JL; Hodgson SE; Abouchedid R; Gerostamoulos D; Maplesden J; Knott J; Hollerer H; Rotella JA; Graudins A; Schumann JL;
Int J Drug Policy; 2023 Dec; 122():104245. PubMed ID: 37944339
[TBL] [Abstract][Full Text] [Related]
6. A multicentre case series of analytically confirmed gamma-hydroxybutyrate intoxications in Western Australian emergency departments: Pre-hospital circumstances, co-detections and clinical outcomes.
Smith JL; Greene S; McCutcheon D; Weber C; Kotkis E; Soderstrom J; Douglas B; Lenton S; Grigg J; Dessauer P; Ezard N; Fatovich DM;
Drug Alcohol Rev; 2024 May; 43(4):984-996. PubMed ID: 38426636
[TBL] [Abstract][Full Text] [Related]
7. Non-fatal intoxications involving the novel benzodiazepine clonazolam: case series from the Emerging Drugs Network of Australia - Victoria project.
Syrjanen R; Greene SL; Castle JW; Di Rago M; Hodgson SE; Abouchedid R; Graudins A; Schumann JL
Clin Toxicol (Phila); 2023 Apr; 61(4):290-293. PubMed ID: 36988452
[TBL] [Abstract][Full Text] [Related]
8. Clinical relevance of ethanol coingestion in patients with GHB/GBL intoxication.
Galicia M; Dargan PI; Dines AM; Yates C; Heyerdahl F; Hovda KE; Giraudon I; ; Wood DM; Miró Ò;
Toxicol Lett; 2019 Oct; 314():37-42. PubMed ID: 31301370
[TBL] [Abstract][Full Text] [Related]
9. Trends in gamma-hydroxybutyrate-related harms based on ambulance attendances from 2012 to 2018 in Victoria, Australia.
Arunogiri S; Moayeri F; Crossin R; Killian JJ; Smith K; Scott D; Lubman DI
Addiction; 2020 Mar; 115(3):473-479. PubMed ID: 31618793
[TBL] [Abstract][Full Text] [Related]
10. Trends in illicit drug emergencies: the emerging role of gamma-hydroxybutyrate.
Miró O; Nogué S; Espinosa G; To-Figueras J; Sánchez M
J Toxicol Clin Toxicol; 2002; 40(2):129-35. PubMed ID: 12126184
[TBL] [Abstract][Full Text] [Related]
11. Chlorpromazine overdose: a case series.
Berling I; Isbister GK
Clin Toxicol (Phila); 2024 Jun; ():1-6. PubMed ID: 38889430
[TBL] [Abstract][Full Text] [Related]
12. Interpreting γ-hydroxybutyrate concentrations for clinical and forensic purposes.
Busardò FP; Jones AW
Clin Toxicol (Phila); 2019 Mar; 57(3):149-163. PubMed ID: 30307336
[TBL] [Abstract][Full Text] [Related]
13. Gamma-hydroxybutyrate: a 30 month emergency department review.
Munir VL; Hutton JE; Harney JP; Buykx P; Weiland TJ; Dent AW
Emerg Med Australas; 2008 Dec; 20(6):521-30. PubMed ID: 19125832
[TBL] [Abstract][Full Text] [Related]
14. Gamma-hydroxybutyrate serum levels and clinical syndrome after severe overdose.
Sporer KA; Chin RL; Dyer JE; Lamb R
Ann Emerg Med; 2003 Jul; 42(1):3-8. PubMed ID: 12827115
[TBL] [Abstract][Full Text] [Related]
15. The clinical toxicology of γ-hydroxybutyrate, γ-butyrolactone and 1,4-butanediol.
Schep LJ; Knudsen K; Slaughter RJ; Vale JA; Mégarbane B
Clin Toxicol (Phila); 2012 Jul; 50(6):458-70. PubMed ID: 22746383
[TBL] [Abstract][Full Text] [Related]
16. Amphetamine toxicity masked by concomitant γ-hydroxybutyrate (GHB) ingestion.
Chien-Po H; An-Yi W
Am J Emerg Med; 2022 Aug; 58():338-339. PubMed ID: 35422350
[TBL] [Abstract][Full Text] [Related]
17. Clinical effects of cannabis compared to synthetic cannabinoid receptor agonists (SCRAs): a retrospective cohort study of presentations with acute toxicity to European hospitals between 2013 and 2020.
Waters ML; Dargan PI; Yates C; Dines AM; Eyer F; Giraudon I; Heyerdahl F; Hovda KE; Liechti ME; Miró Ò; Vallersnes OM; Anseeuw K; Badaras R; Bitel M; Bonnici J; Brvar M; Caganova B; Calýskan F; Ceschi A; Chamoun K; Daveloose L; Galicia M; Gartner B; Gorozia K; Grenc D; Gresnigt FMJ; Hondebrink L; Jürgens G; Konstari J; Kutubidze S; Laubner G; Liakoni E; Liguts V; Lyphout C; McKenna R; Mégarbane B; Moughty A; Nitescu GV; Noseda R; O'Connor N; Paasma R; Ortega Perez J; Perminas M; Persett PS; Põld K; Puchon E; Puiguriguer J; Radenkova-Saeva J; Rulisek J; Samer C; Schmid Y; Scholz I; Stašinskis R; Surkus J; Van den Hengel-Koot I; Vigorita F; Vogt S; Waldman W; Waring WS; Zacharov S; Zellner T; Wood DM
Clin Toxicol (Phila); 2024 Jun; ():1-7. PubMed ID: 38934347
[TBL] [Abstract][Full Text] [Related]
18. Sedative and hypothermic effects of gamma-hydroxybutyrate (GHB) in rats alone and in combination with other drugs: assessment using biotelemetry.
van Nieuwenhuijzen PS; McGregor IS
Drug Alcohol Depend; 2009 Aug; 103(3):137-47. PubMed ID: 19446408
[TBL] [Abstract][Full Text] [Related]
19. Cocaine, metamfetamine, and MDMA abuse: the role and clinical importance of neuroadaptation.
Seger D
Clin Toxicol (Phila); 2010 Aug; 48(7):695-708. PubMed ID: 20849328
[TBL] [Abstract][Full Text] [Related]
20. Toxicity evaluation of α-pyrrolidinovalerophenone (α-PVP): results from intoxication cases within the STRIDA project.
Beck O; Franzén L; Bäckberg M; Signell P; Helander A
Clin Toxicol (Phila); 2016 Aug; 54(7):568-75. PubMed ID: 27412885
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
